Opportunity ID: 338789

General Information

Document Type: Grants Notice
Funding Opportunity Number: HRSA-22-145
Funding Opportunity Title: Hereditary Hemorrhagic Telangiectasia (HHT) Center
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation: https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=7a5df7f7-eb80-4ffe-8a6d-f837e47bafa2
Expected Number of Awards: 1
Assistance Listings: 93.110 — Maternal and Child Health Federal Consolidated Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 18, 2022
Last Updated Date: Mar 18, 2022
Original Closing Date for Applications: May 17, 2022
Current Closing Date for Applications: May 17, 2022
Archive Date:
Estimated Total Program Funding: $2,000,000
Award Ceiling: $2,000,000
Award Floor: $0

Eligibility

Eligible Applicants: Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Small businesses
State governments
Special district governments
Additional Information on Eligibility: Any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)) is eligible to apply. See 42 CFR § 51a.3(a)). Domestic faith-based and community-based organizations are eligible to apply.

Additional Information

Agency Name: Health Resources and Services Administration
Description: The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Department of Health and Human Services, Health Resources and Services Administration
cnovoa@hrsa.gov
Email:cnovoa@hrsa.gov

Version History

Version Modification Description Updated Date

Folder 338789 Full Announcement-HRSA-22-145 -> MCHB HRSA-22-145 (UP4) HHT_Final.pdf

Packages

Agency Contact Information: Department of Health and Human Services, Health Resources and Services Administration
cnovoa@hrsa.gov
Email: cnovoa@hrsa.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.110 HRSA-22-145 Hereditary Hemorrhagic Telangiectasia (HHT) Center PKG00272658 Mar 18, 2022 May 17, 2022 View

Package 1

Mandatory forms

338789 SF424_4_0-4.0.pdf

338789 AttachmentForm_1_2-1.2.pdf

338789 PerformanceSite_4_0-4.0.pdf

338789 ProjectNarrativeAttachments_1_2-1.2.pdf

338789 GG_LobbyingForm-1.1.pdf

338789 BudgetNarrativeAttachments_1_2-1.2.pdf

338789 SF424A-1.0.pdf

338789 Key_Contacts_2_0-2.0.pdf

338789 Project_AbstractSummary_2_0-2.0.pdf

Optional forms

338789 SFLLL_2_0-2.0.pdf

2025-07-12T16:44:43-05:00

Share This Post, Choose Your Platform!

About the Author: